Talking Precision Medicine
Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space.
- Indexed episodes, last 90 days
- 3
- Latest publication
- Sep 17, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 21, 2026
Latest episodes
Andrii Buvailo | The Kodak moment for drug discovery: AI, adaptation, and what stays human | TPM podcast #61 (opens the original)
Read excerpt
Are we measuring progress in AI-driven drug discovery the right way? Rafael Rosengarten explores this question with Andrii Buvailo , co-founder of BioPharmaTrend and one of the industry’s most perceptive analysts of AI in biotech and pharma. They trace the evolution of AI-driven drug discovery, examine why counting AI-discovered drugs gives an incomplete picture of progress, and explore where AI can create value today. Andrii also considers why the technology has become so polarizing, what remai
Tim Wahlberg | What would you (and your AI) do with the world’s largest curated chemistry data catalog? | TPM podcast #60 (opens the original)
Read excerpt
Artificial intelligence may be transforming drug discovery, but AI is only as powerful as the data it learns from. Behind many of today's scientific breakthroughs sits an invisible layer of expertly curated, harmonized knowledge that allows researchers to ask better questions and trust the answers. In this episode, Rafael speaks with Tim Walberg , President of CAS, about why scientific data curation remains essential in the age of large language models, how CAS has evolved from Chemical Abstract
Jacob Hooker | From motifs to medicines: Harnessing nature’s pharmacopeia for novel CNS therapies | TPM podcast #59 (opens the original)
Read excerpt
Mental health remains one of medicine's greatest unmet needs. In this episode, Jacob Hooker explains how Sensorium Therapeutics is searching for new psychiatric medicines by combining traditional plant knowledge with cutting-edge drug development. Jacob joins Rafael Rosengarten to discuss how centuries of ethnobotanical knowledge, modern AI, and medicinal chemistry are helping uncover new treatments for anxiety, epilepsy, and cognitive disorders. Along the way, they explore the science behind ps
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.